{"id":3315,"date":"2022-01-17T08:24:09","date_gmt":"2022-01-17T08:24:09","guid":{"rendered":"https:\/\/aceoncology.org\/?p=3315"},"modified":"2022-01-17T08:24:10","modified_gmt":"2022-01-17T08:24:10","slug":"polatuzumab-combo-outperforms-r-chop-in-dlbcl","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/","title":{"rendered":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP"},"content":{"rendered":"\n<p>\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08DLBCL\uff09\u662f\u6700\u5e38\u89c1\u7684\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7c7b\u578b\uff0c\u5176\u6807\u51c6\u6cbb\u7597\u662f\u5229\u59a5\u6614\u5355\u6297\u3001\u73af\u78f7\u9170\u80fa\u3001\u591a\u67d4\u6bd4\u661f\u3001\u957f\u6625\u65b0\u78b1\u548c\u6cfc\u5c3c\u677e\uff08R-CHOP\uff09\u65b9\u6848\u3002\u7136\u800c\uff0c\u4f7f\u7528R-CHOP\u65b9\u6848\uff0c\u9ad8\u8fbe40%\u7684\u60a3\u8005\u96be\u6cbb\u6216\u5728\u521d\u59cb\u6cbb\u7597\u7f13\u89e3\u540e\u590d\u53d1\u3002\u7814\u7a76\u4eba\u5458\u7814\u7a76\u4e86\u66ff\u4ee3\u65b9\u6cd5\uff0c\u5305\u62ec\u5f3a\u5316\u5316\u7597\u6216\u5229\u59a5\u6614\u5355\u6297\u6cbb\u7597\u90e8\u5206\u3001\u6dfb\u52a0\u7ef4\u6301\u6cbb\u7597\u6216\u5c1d\u8bd5\u65b0\u578b\u836f\u7269\uff0c\u5747\u672a\u5e26\u6765\u5bf9\u6cbb\u7597\u7ed3\u5c40\u6709\u610f\u4e49\u7684\u6539\u5584\u3002\u6700\u8fd1\uff0c\u6297CD79b\u6297\u4f53\u5076\u8054\u836f\u7269\uff08ADC\uff09polatuzumab vedotin\u5728DLBCL\u60a3\u8005\u4e2d\u663e\u793a\u51fa\u5355\u836f\u6cbb\u7597\u4ee5\u53ca\u4e0e\u5229\u59a5\u6614\u5355\u6297\u548c\u5229\u59a5\u6614\u5355\u6297\/\u82ef\u8fbe\u83ab\u53f8\u6c40\u8054\u5408\u6cbb\u7597\u7684\u524d\u666f\u3002\u5728POLARIX\u7814\u7a76\u4e2d\uff0c\u7814\u7a76\u8005\u8bc4\u4f30\u4e86polatuzumab vedotin\u8054\u5408\u5229\u59a5\u6614\u5355\u6297\u3001\u73af\u78f7\u9170\u80fa\u3001\u591a\u67d4\u6bd4\u661f\u548c\u6cfc\u5c3c\u677e\uff08pola-R-CHP\uff09\u4e0eR-CHOP\u76f8\u6bd4\u6cbb\u7597DLBCL\u521d\u6cbb\u60a3\u8005\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u3002\u8fd9\u9879\u968f\u673a\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001\u56fd\u9645\u3001III\u671f\u7814\u7a76\u7684\u7ed3\u679c\u4e8e<a href=\"https:\/\/ash.confex.com\/ash\/2021\/webprogram\/Paper154729.html\">2021\u5e7412\u6708\u5728\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\u4e0a\u516c\u5e03<\/a>\uff0c<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2115304\">\u540c\u65f6\u53d1\u8868\u5728\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\u4e0a\u3002<\/a><\/p>\n\n\n\n<p>\u603b\u8ba1879\u4f8bCD20\u9633\u6027DLBCL\u6210\u4eba\u60a3\u8005\u968f\u673a\u63a5\u53d76\u4e2a\u5468\u671f\u7684pola-R-CHP\u6216R-CHOP\u6cbb\u7597\u4ee5\u53ca2\u4e2a\u5468\u671f\u7684\u5229\u59a5\u6614\u5355\u6297\u5355\u836f\u6cbb\u7597\u3002\u4e3b\u8981\u7ec8\u70b9\u662f\u7531\u7814\u7a76\u8005\u8bc4\u4f30\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u3002\u6b21\u8981\u7ec8\u70b9\u5305\u62ec\u603b\u751f\u5b58\u671f\u548c\u5b89\u5168\u6027\u3002\u4e2d\u4f4d\u968f\u8bbf28.2\u4e2a\u6708\u540e\uff0cpola-R-CHP\u7ec4\u76842\u5e74PFS\u8f83\u9ad8\uff0c\u4e3a76.7%\uff0c\u800cR-CHOP\u7ec4\u4e3a70.2%\u3002pola-R-CHP\u7ec4\u75be\u75c5\u8fdb\u5c55\u6216\u6b7b\u4ea1\u7684\u98ce\u9669\u964d\u4f4e27%\uff08\u98ce\u9669\u6bd4[HR]=0.73\uff0cP = 0.02\uff09\u3002\u6709\u610f\u601d\u7684\u662f\uff0c\u63a2\u7d22\u6027\u4e9a\u7ec4\u5206\u6790\u7684\u7ed3\u679c\u6839\u636e\u4eba\u53e3\u7edf\u8ba1\u5b66\u548c\u75be\u75c5\u7279\u5f81\u800c\u53d8\u5316\u3002\u572860\u5c81\u4ee5\u4e0a\u3001\u56fd\u9645\u9884\u540e\u6307\u6570\u8bc4\u52063-5\u5206\u548cDLBCL\u6d3b\u5316B\u7ec6\u80de\u6837\u4e9a\u578b\u7684\u60a3\u8005\u4e2d\u89c2\u5bdf\u5230pola-R-CHP\u7684\u660e\u663ePFS\u83b7\u76ca\uff0c\u4f46\u5728\u5176\u4ed6\u4e9a\u7ec4\u4e2d\u672a\u89c2\u5bdf\u5230\u3002\u4e24\u7ec4\u7684\u603b\u751f\u5b58\u7387\u51e0\u4e4e\u76f8\u540c\uff0cpola-R-CHP\u7ec4\u548cR-CHOP\u7ec4\u5206\u522b\u4e3a88.7%\u548c88.6%\uff08HR=0.94\uff0cP = 0.75\uff09\u3002\u540c\u6837\u5730\uff0c\u6cbb\u7597\u7ed3\u675f\u65f6\u8fbe\u5230CR\u7684\u60a3\u8005\u767e\u5206\u6bd4\u4e5f\u76f8\u5f53\uff1apola-R-CHP\u7ec4\u548cR-CHOP\u7ec4\u5206\u522b\u4e3a78.0%\u548c74.0%\uff08P = 0.16\uff09\u3002\u7136\u800c\uff0c\u7814\u7a76\u8005\u53d1\u73b0pola-R-CHP\u6cbb\u7597\u540e\u8fbe\u5230CR\u7684\u60a3\u8005\u6bd4R-CHOP\u7ec4\u66f4\u6709\u53ef\u80fd\u4fdd\u6301\u7f13\u89e3\uff08HR=0.70\uff09\u3002<\/p>\n\n\n\n<p>\u603b\u4f53\u800c\u8a00\uff0c\u4e24\u7ec4\u7684\u5b89\u5168\u6027\u6570\u636e\u76f8\u4f3c\u3002\u6b63\u5982\u9884\u671f\uff0cpola-R-CHP\u7684\u5b89\u5168\u6027\u7279\u5f81\u4e0e\u5404\u836f\u7269\u7684\u5df2\u77e5\u5b89\u5168\u6027\u7279\u5f81\u4e00\u81f4\u3002\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u75c7\u3001\u53d1\u70ed\u6027\u4e2d\u6027\u7c92\u7ec6\u80de\u51cf\u5c11\u75c7\u548c\u8d2b\u8840\u662f\u6700\u5e38\u62a5\u544a\u76843\u7ea7\u62164\u7ea7\u4e0d\u826f\u4e8b\u4ef6\uff08AE\uff09\u3002\u4e24\u7ec4\u4e2d\u7ea61\/3\u7684\u60a3\u8005\u53d1\u751f\u4e25\u91cdAE\uff08pola-R-CHP\u7ec4\u548cR-CHOP\u7ec4\u5206\u522b\u4e3a34%\u548c30.6%\uff09\u30022\u7ec4\u4e2d\u7684\u81f4\u6b7b\u6027\u6cbb\u7597\u76f8\u5173AE\u6700\u5e38\u4e0e\u611f\u67d3\u76f8\u5173\uff1apola-R-CHP\u7ec4\u548cR-CHOP\u7ec4\u5206\u522b\u4e3a13\u548c10\u4f8b\u3002\u5c3d\u7ba1\u5468\u56f4\u795e\u7ecf\u75c5\u53d8\u662fpolatuzumab ADC\u6cbb\u7597\u7684\u9884\u671fAE\uff0c\u4f46pola-R-CHP\u7ec4\u4e0eR-CHOP\u7ec4\u95f4\u7684\u53d1\u751f\u7387\u65e0\u5dee\u5f02\uff08\u5206\u522b\u4e3a52.9%\u548c53.9%\uff09\uff0c\u4e14\u591a\u4e3a1\u7ea7\u3002\u4f5c\u8005\u5f3a\u8c03\u4e86pola-R-CHP\u76f8\u6bd4R-CHOP\u7684PFS\u83b7\u76ca\uff0c\u5e76\u6307\u51fa\u9700\u8981\u66f4\u957f\u65f6\u95f4\u7684\u968f\u8bbf\u4ee5\u8bc1\u5b9e2\u5e74\u7f13\u89e3\u662f\u53ef\u8010\u53d7\u7684\u4e14\u5bf9\u603b\u751f\u5b58\u671f\u5e26\u6765\u5f71\u54cd\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e\uff1a<\/strong><br>Tilly H, et al. <em>N Engl J Med<\/em>. 2021 Dec 14. [Online ahead of print.]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08DLBCL\uff09\u662f\u6700\u5e38\u89c1\u7684\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u7c7b\u578b\uff0c\u5176\u6807\u51c6\u6cbb\u7597\u662f\u5229\u59a5\u6614\u5355\u6297\u3001\u73af\u78f7\u9170\u80fa\u3001\u591a\u67d4\u6bd4\u661f\u3001\u957f [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":3310,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[86],"tags":[],"class_list":["post-3315","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-86"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-17T08:24:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-17T08:24:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP\",\"datePublished\":\"2022-01-17T08:24:09+00:00\",\"dateModified\":\"2022-01-17T08:24:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\"},\"wordCount\":77,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg\",\"articleSection\":[\"\u6587\u7ae0\u4eae\u70b9\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\",\"name\":\"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg\",\"datePublished\":\"2022-01-17T08:24:09+00:00\",\"dateModified\":\"2022-01-17T08:24:10+00:00\",\"description\":\"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg\",\"width\":2400,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology","description":"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/","og_locale":"zh_CN","og_type":"article","og_title":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology","og_description":"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f","og_url":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/","og_site_name":"ACE Oncology","article_published_time":"2022-01-17T08:24:09+00:00","article_modified_time":"2022-01-17T08:24:10+00:00","og_image":[{"width":2400,"height":2000,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg","type":"image\/jpeg"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP","datePublished":"2022-01-17T08:24:09+00:00","dateModified":"2022-01-17T08:24:10+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/"},"wordCount":77,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg","articleSection":["\u6587\u7ae0\u4eae\u70b9"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/","url":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/","name":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg","datePublished":"2022-01-17T08:24:09+00:00","dateModified":"2022-01-17T08:24:10+00:00","description":"\u672a\u7ecf\u6cbb\u7597\u7684\u9ad8\u5371DLBCL\u60a3\u8005\u4e2d\uff0c\u4e0eR-CHOP\u76f8\u6bd4\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u5ef6\u957f\u751f\u5b58\u671f","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/01\/Blog-73-Polarix-DLBCL_Picture.jpg","width":2400,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/polatuzumab-combo-outperforms-r-chop-in-dlbcl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5bf9\u4e8eDLBCL\u521d\u6cbb\u60a3\u8005\uff0c\u57fa\u4e8ePolatuzumab\u7684\u8054\u5408\u6cbb\u7597\u6548\u679c\u8d85\u8d8aR-CHOP"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=3315"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3315\/revisions"}],"predecessor-version":[{"id":3316,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/3315\/revisions\/3316"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/3310"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=3315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=3315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=3315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}